Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines ...

Heather Gay exclusively tells Us Weekly why GLP-1s are central to her plan to maintain her weight loss alongside Atkins ...

This executive summary provides an overview of the 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, which is organized around the Utstein ...

Novo Nordisk today announced that its weight-loss drug, Wegovy (semaglutide 2.4mg), is now officially available in Malaysia, ...

For years, endocrinologist Leigh Perreault, MD, felt there had to be a better way to help patients with weight management ...

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...

The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...

Arkansas state laws that create an income tax credit for businesses that relocate their corporate headquarters in Arkansas and require coverage of treatment and conditions caused by severe obesity are ...

TUESDAY, Dec. 30, 2025 (HealthDay News) — While childhood obesity has become more common in recent years, this is a condition that is about more than just weight. Childhood obesity reflects our modern ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...